CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2022; 13(01): 061-064
DOI: 10.1055/s-0041-1728234
News

Endoscopic Ultrasound for Detection of Liver Metastasis: Hope or Hype?

Anupam Kumar Singh
1   Department of Gastroenterology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Surinder S. Rana
1   Department of Gastroenterology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
› Author Affiliations

Abstract

Transabdominal ultrasonography, contrast-enhanced computed tomography, and magnetic resonance imaging (MRI) are the common diagnostic tests for the detection of hepatic lesions. Use of enhanced and advanced MRI technique, that is, diffusion weighted MRI and hepatocyte-specific contrast agents, has further improved the accuracy of detection of metastatic liver lesions ≤ 10 mm in diameter. However, even with these advanced imaging modalities sensitivity is low for lesions smaller than 10 mm when compared with standard intraoperative ultrasound. Endoscopic ultrasound (EUS) is an emerging imaging modality with resolution sufficient to detect and sample lesions as small as 5 mm in diameter. In this news and views, we have discussed the role of standard and enhanced EUS for the detection of metastatic liver lesions.



Publication History

Article published online:
03 June 2021

© 2022. Society of Gastrointestinal Endoscopy of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Sheth KR, Clary BM. Management of hepatic metastases from colorectal cancer. Clin Colon Rectal Surg 2005; 18 (03) 215-223
  • 2 Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer 2018; 18 (01) 78
  • 3 Oliva MR, Saini S. Liver cancer imaging: role of CT, MRI, US and PET. Cancer Imaging 2004; 4 Spec No A: S42-S46
  • 4 Hong SB, Choi SH, Kim KW. et al. Diagnostic performance of [18F]FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis. Eur Radiol 2019; 29 (07) 3553-3563
  • 5 Krill T, Baliss M, Roark R. et al. Accuracy of endoscopic ultrasound in esophageal cancer staging. J Thorac Dis 2019; 11 (Suppl. 12) S1602-S1609
  • 6 Kitano M, Yoshida T, Itonaga M, Tamura T, Hatamaru K, Yamashita Y. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. J Gastroenterol 2019; 54 (01) 19-32
  • 7 NICE Guideline Updates Team (UK). Evidence reviews for effectiveness of non-ultrasound-guided TBNA, EBUS-TBNA or EUS-FNA for people with a probability of mediastinal malignancy: Lung cancer: diagn\osis and management: Evidence review A. London: National Institute for Health and Care Excellence (UK); 2019
  • 8 Campos S, Poley JW, van Driel L, Bruno MJ. The role of EUS in diagnosis and treatment of liver disorders. Endosc Int Open 2019; 7 (10) E1262-E1275
  • 9 Jiang TA, Deng Z, Tian G, Zhao QY, Wang WL. Efficacy and safety of endoscopic ultrasonography-guided interventional treatment for refractory malignant left-sided liver tumors: a case series of 26 patients. Sci Rep 2016; 6: 36098 DOI: 10.1038/srep36098.
  • 10 Dhadham GC, Hoffe S, Harris CL, Klapman JB. Endoscopic ultrasound-guided fiducial marker placement for image-guided radiation therapy without fluoroscopy: safety and technical feasibility. Endosc Int Open 2016; 4 (03) E378-E382
  • 11 Matthes K, Sahani D, Holalkere NS, Mino-Kenudson M, Brugge WR. Feasibility of endoscopic ultrasound-guided portal vein embolization with Enteryx. Acta Gastroenterol Belg 2005; 68 (04) 412-415
  • 12 Lee S, Seo DW, Paik WH. et al. Ethanol lavage of huge hepatic cysts by using EUS guidance and a percutaneous approach. Gastrointest Endosc 2014; 80 (06) 1014-1021
  • 13 Schölmerich J, Volk BA, Gerok W. Value and limitations of abdominal ultrasound in tumour staging–liver metastasis and lymphoma. Eur J Radiol 1987; 7 (04) 243-245
  • 14 Lundstedt C, Ekberg H, Hederström E, Stridbeck H, Torfason B, Transberg KG. Radiologic diagnosis of liver metastases in colo-rectal carcinoma. Prospective evaluation of the accuracy of angiography, ultrasonography, computed tomography and computed tomographic angiography. Acta Radiol 1987; 28 (04) 431-438
  • 15 Wernecke K, Rummeny E, Bongartz G. et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR Am J Roentgenol 1991; 157 (04) 731-739
  • 16 Bipat S, van Leeuwen MS, Comans EF. et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis–meta-analysis. Radiology 2005; 237 (01) 123-131
  • 17 Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002; 224 (03) 748-756
  • 18 Holalkere NS, Sahani DV, Blake MA, Halpern EF, Hahn PF, Mueller PR. Characterization of small liver lesions: added role of MR after MDCT. J Comput Assist Tomogr 2006; 30 (04) 591-596
  • 19 Kim HJ, Lee SS, Byun JH. et al. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology 2015; 274 (03) 712-722
  • 20 Granata V, Fusco R, de Lutio di Castelguidone E. et al. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection. BMC Gastroenterol 2019; 19 (01) 129 DOI: 10.1186/s12876-019-1036-7.
  • 21 Singh P, Mukhopadhyay P, Bhatt B. et al. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: results of a prospective comparative study. J Clin Gastroenterol 2009; 43 (04) 367-373
  • 22 McGrath K, Brody D, Luketich J, Khalid A. Detection of unsuspected left hepatic lobe metastases during EUS staging of cancer of the esophagus and cardia. Am J Gastroenterol 2006; 101 (08) 1742-1746
  • 23 Minaga K, Kitano M, Nakai A. et al. Improved detection of liver metastasis using Kupffer-phase imaging in contrast-enhanced harmonic EUS in patients with pancreatic cancer (with video). Gastrointest Endosc 2020
  • 24 Prasad P, Schmulewitz N, Patel A. et al. Detection of occult liver metastases during EUS for staging of malignancies. Gastrointest Endosc 2004; 59 (01) 49-53
  • 25 Nguyen P, Feng JC, Chang KJ. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc 1999; 50 (03) 357-361
  • 26 Fujii-Lau LL, Abu Dayyeh BK, Bruno MJ. et al. EUS-derived criteria for distinguishing benign from malignant metastatic solid hepatic masses. Gastrointest Endosc 2015; 81 (05) 1188-96.e1, 7
  • 27 Kitano M, Kudo M, Yamao K. et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol 2012; 107 (02) 303-310
  • 28 Napoleon B, Alvarez-Sanchez MV, Gincoul R. et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy 2010; 42 (07) 564-570